Tag: CORO
Asthma Exacerbations Up After Relaxation of COVID-19 Restrictions
Relaxation of restrictions coincided with increasing incidence of COVID-19, non-COVID-19 ARI, severe asthma exacerbations
New Pfizer Booster Shot Shows Protection Against Emerging Omicron Variants
In early data, new Pfizer COVID-19 boosters marshal antibodies against newer omicron variants
COVID-19 Not Tied to Worse Inflammatory Bowel Disease Outcomes
Findings based on primary composite outcome of IBD-related hospitalization or surgery with 394 days of median follow-up
Seizures, Epilepsy Up in Six Months After COVID-19 Infection
Hazard ratio of seizures and epilepsy greater after COVID-19 versus influenza for those who were not hospitalized and those aged younger than 16 years
Seroprevalence to SARS-CoV-2 Has Increased Over Time
Global seroprevalence from infection or vaccination reached 59.2 percent by September 2021
Severe Outcomes From COVID-19 Up With Preexisting Neuropsych Conditions
Neuropsychiatric conditions and/or associated treatment linked to increased risk for severe outcomes from COVID-19, SARIs
Hospitalizations Up Among Infants Younger Than 6 Months During Omicron
No increase seen in prevalence of indicators of severe disease among these hospitalized infants
Adverse Events Mild, Rare With mAb Treatment for COVID-19 in Pregnancy
No differences seen in any obstetric-associated outcome or in composite 28-day COVID-19 outcome
SARS-CoV-2 Reinfection Ups Risks for Death, Hospitalization
Risks were increased, regardless of vaccination status, and increased according to number of reinfections
Moderna Booster Shot Prompts Strong Immune Response Against Omicron Subvariants
Moderna reports its updated booster shot is indeed triggering a strong immune response to the omicron variants BA.5 and BA.4
